embryos; embryos null for Rala and Ralb do not live past gastrulation. Using a Kras-driven non-small cell lung carcinoma mouse model, we found that either RALA or RALB is sufficient for tumor growth. However, deletion of both Ral genes blocks tumor formation. Either RALA or RALB is sufficient for cell proliferation, but cells lacking both fail to proliferate. These studies demonstrate functions of RAL proteins in development, tumorigenesis, and cell proliferation and show that RALA and RALB act in a redundant fashion.
RAL small GTPases, encoded by the Rala and Ralb genes, are members of the RAS superfamily of small GTPases and can act as downstream effectors of RAS [1] . Although highly similar, distinct functions have been identified for RALA and RALB: RALA has been implicated in epithelial cell polarity [2] , insulin secretion [3] , GLUT4 translocation [4, 5] , neurite branching, and neuronal polarity [6, 7] , and RALB in tumor cell survival [8] , migration/invasion [9] [10] [11] [12] , TBK1 activation [13] , and autophagy [14] . To investigate RAL GTPases in vivo, we generated null and conditional knockout mice. Ralb null mice are viable with no overt phenotype; the Rala null leads to exencephaly and embryonic lethality. The exencephaly phenotype is exacerbated in Rala 2/2 ;Ralb +/2 embryos; embryos null for Rala and Ralb do not live past gastrulation. Using a Kras-driven non-small cell lung carcinoma mouse model, we found that either RALA or RALB is sufficient for tumor growth. However, deletion of both Ral genes blocks tumor formation. Either RALA or RALB is sufficient for cell proliferation, but cells lacking both fail to proliferate. These studies demonstrate functions of RAL proteins in development, tumorigenesis, and cell proliferation and show that RALA and RALB act in a redundant fashion.
Results and Discussion

RAL Small GTPases Are Required for Neural Tube Closure in the Mouse
To investigate the functions of RAL GTPases in mouse development and tumorigenesis, we generated null and conditional alleles of the Rala and Ralb loci using the Cre-lox system. The Rala and Ralb genes have similar intron-exon structures, with five exons and the translation start site located in exon 2. We flanked exons 2 and 3 in Rala and exon 2 in Ralb with LoxP sites (see Figures S1A-S1D available online). To obtain null alleles, mice carrying the targeted alleles were crossed to the PGK-Cre transgenic strain. Intercrossing Ralb +/2 mice generated Ralb null pups at the expected Mendelian ratio that were viable, displayed no obvious abnormalities ( Figure 1D ), and developed to fertile adults. Rala +/2 intercrosses did not generate Rala null mice, implying that Rala is required for embryonic development. We confirmed the loss of RALA and RALB proteins in null mouse embryonic fibroblasts (MEFs) ( Figures 1A and 1B) and loss of RALB proteins in tissues of adult mice ( Figure 1C ). The expression of RALB proteins was unchanged in Rala null cells and vice versa.
To investigate the role of RALA in embryonic development, we examined embryos from Rala +/2 intercrosses. Between embryonic day 10.5 (E10.5) and E19.5, we observed that 10 out of 33 of the Rala null embryos displayed exencephaly ( Figures 1E and 1F ), a condition caused by a failure of closure of the neural tube along the hindbrain region [15] . We also observed exencephaly in Rala null embryos generated from a gene-trap embryonic stem (ES) clone (Figures 1G and S1E-S1I). To examine whether RALA and RALB have overlapping functions in neural tube closure, we generated compound mutants: 14 of 14 Rala
2/2
;Ralb +/2 embryos displayed a severe neural tube defect (NTD) at E10.5-E13. 5 , with open neural tube at the forebrain/midbrain boundary and hindbrain/cervical boundary, as well as caudally ( Figures 1H-1J ). These embryos also exhibited developmental retardation. We did not observe NTDs in Rala +/2 ;Ralb 2/2 embryos (0 of 8), although some of them displayed developmental retardation. These observations demonstrate a role for RALA during neural tube closure that can only be partially compensated by RALB. Importantly, we failed to identify Rala 2/2 ;Ralb 2/2 embryos between E10.5 and E13.5, establishing that RALA and RALB share functions that are essential during early embryogenesis ( Figure 1J ). In further support of the conclusion that RALA and RALB have overlapping functions, we found that when the Ral-floxed alleles were crossed to an adipocyte-specific Cre [16] , absence of either RALA or RALB in adipocytes had no effect on viability, but absence of both RAL proteins led to perinatal lethality (data not shown).
RALA and RALB Act Redundantly in RAS-Driven Tumorigenesis
To investigate the functions of RALA and RALB in RAS-mediated tumorigenesis, we crossed the Ral-targeted mice to the LSL-Kras G12D non-small cell lung carcinoma (NSCLC) model, where the expression of an oncogenic allele of Kras requires the excision of a LoxP-stop-LoxP cassette by Cre recombinase [17] . This mouse model develops tumors that are histologically similar to human adenocarcinoma, 30% of which harbor KRAS mutations [18] .
Because Rala null mice exhibit embryonic lethality, we used mice with two copies of the Rala lox conditional allele so that excision of Rala only occurred in lung epithelial cells expressing Cre recombinase. Because Ralb null mice are viable, we used null (Ralb ) alleles. Cohorts were treated with adenovirus expressing Cre (AdCre) and sacrificed 6 months later [17, 19] . Histological analysis revealed a similar number of tumors and tumor grade distribution among WT, Rala lox/lox , Ralb lox/2
, and Ralb 2/2 animals (Figures 2A and 2D ). We quantified tumor burden by measuring the volume of lesions via microcomputed tomography (microCT) imaging, which revealed no significant difference between the genotypes ( Figure 2G ). To show whether Rala lox alleles were efficiently recombined in tumors, we performed immunohistochemistry (IHC) on lung cross-sections with an anti-RALA antibody ( Figures 2E and 2F) ; 80% of tumors in Rala lox/lox mice had completely lost RALA expression (Figure 2H) . Hence, the absence of RALA or RALB does not affect the formation of NSCLC. We obtained similar results using the 7,12-dimethylbenzanthracene-12-O-tetradecanoylphorbol-13-acetate (DMBA-TPA)-induced, Hras-driven skin carcinogenesis tumor model [20] using Ralb null mice or K14-Cre [21] and Rala lox/lox alleles to specifically excise Rala from the epidermis; in both cases, tumor formation was not impaired ( Figure S3 ).
Because the deletion of either Rala or Ralb has no apparent effect on the formation of NSCLC, we tested whether deleting both RAL GTPases would impair NSCLC formation. 3B ). Histological analysis showed a 60% decrease in tumor area ( Figure 3E ). Similarly, quantification of tumor burden by microCT showed a 60% decrease in Kras G12D ; Rala lox/lox ;Ralb 2/2 mice ( Figure 3F ). In marked contrast to tumors in Kras
G12D
;Rala lox/lox animals ( Figure 2H ), we observed that RALA was expressed in all tumors arising in Kras
; Rala lox/lox ;Ralb 2/2 mice ( Figures 3D and 3G ). These data show that RAL function is essential for tumorigenesis in this NSCLC model, the expression of either RALA or RALB being sufficient.
Redundant Activity of RALA and RALB in Cell Proliferation
To investigate whether the requirement for RAL GTPases in tumor formation reflects a role in cell proliferation, we generated Rala
, and Rala lox/lox ;Ralb 2/2 MEFs and examined their ability to proliferate. Rala and Ralb null MEFs proliferated as well as their WT counterparts ( Figure 4A ). To rule out selection for a compensatory mechanism during embryogenesis, we infected Rala lox/lox and Ralb lox/lox MEF populations with adenovirus expressing Cre and green fluorescent protein (AdCreGFP) and observed that they proliferated as well as their counterparts infected with adenovirus expressing GFP alone (data not shown). However, three independent populations of Rala lox/lox ;Ralb 2/2 MEFs infected with AdCreGFP viruses failed to proliferate ( Figure 4B ). The efficiency of excision was confirmed by western blotting (Figure 4C ). Hence, deletion of both RAL GTPases seriously impairs the ability of MEFs to proliferate. We assume that the proliferating cells in the AdCreGFP-infected Rala lox/lox ; Ralb 2/2 MEF population retained RALA expression. Consistent with this, although we were able to select WT MEF populations stably expressing Cre recombinase using a retrovirus encoding Cre, we were unable to do this with Rala lox/lox ; Ralb 2/2 MEFs. We have shown that RAL function is essential for cell proliferation, but the fact that either RALA or RALB is sufficient implies that they act redundantly. This redundancy raises the issue of whether there is compensatory activation of a RAL isoform in the absence of the other isoform; therefore, we measured the amount of activated GTP-loaded RALB in Rala null MEFs and vice versa. We observed that RALB-GTP was significantly increased in Rala null MEFs (Figures 4D and 4E ) and that RALA-GTP was increased in Ralb null MEFs ( Figures  4F and 4G ). This increase in activation occurred without any 4F ). We obtained similar results using MEFs carrying Ral-floxed alleles infected with AdCreGFP (data not shown). Hence, the loss of one RAL protein is partially compensated by an increase in the activation of the other isoform, suggesting that it is the overall level of RAL activity that is important rather than a specific isoform. The different functions ascribed to RALA and RALB have been rationalized in part by different subcellular localizations [2, 22] . To investigate subcellular localization, we generated HeLa and MEF cell populations stably coexpressing mCherry-RALA and GFP-RALB at levels similar to the endogenous proteins. In both cell types, most RALA and RALB proteins colocalize at interphase (HeLa, thresholded Pearson's correlation coefficient [PCC] > 0.600), the majority of RAL proteins being present at the plasma membrane while a fraction are on intracellular puncta, as previously reported (HeLa, Figure S4 ; MEFs, data not shown) [2, 23, 24] . However, every cell examined displayed intracellular structures that were positive for RALA but not RALB. The identity of the structures remains to be determined. Interestingly, an even higher fraction of RALA and RALB proteins colocalized during the different stages of mitosis (HeLa, thresholded PCC > 0.750) ( Figure S4 ).
Vertebrate Rala and Ralb genes derive from a common ancestor in metazoa and fungi, Rala being most similar to its metazoan orthologs [25] . Despite the high similarity between RALA and RALB proteins, many studies have attributed different functions to the isoforms. However, no previous work has used rigorous germline approaches; therefore, to investigate the role of RALA and RALB in mouse development and tumorigenesis, we generated null and conditional alleles. We found that RALA but not RALB is required for embryonic development, implying that RALA has a unique role. Ralb null mice develop apparently normally and are viable and fertile. Nearly 30% of Rala null embryos displayed exencephaly; 100% of Rala 2/2 ;Ralb +/2 embryos displayed a more severe NTD. This indicates that RALA has a specific function in neural tube closure but that RALB is also involved. Possibly the unique requirement for RALA may reflect differences in expression rather than protein function, although it has been reported that both Ral genes have very similar expression patterns between E9.5 and E16.5 [26] .
Strikingly, we observed that either RALA or RALB is sufficient for proliferation of MEFs in culture but that deletion of both Rala and Ralb blocks proliferation. Together with the more severe NTD in Rala 2/2 ; Ralb +/2 embryos, these data argue for overlapping, redundant functions of RAL proteins. The requirement for RAL GTPases for cell proliferation may explain the early lethality of the Rala 2/2 ;Ralb 2/2 embryos because no embryos were present at E10.5. The redundancy of RAL GTPases in cell proliferation that we observed contrasts with a reported nonredundant function during cytokinesis, where HeLa cells depleted of RALA and RALB have a binucleated phenotype similar to cells depleted of RALA only [27] . The fact that a cell proliferation defect was See also Figure S2 .
not observed under RNAi conditions may be because complete depletion of RAL proteins is required to reveal this phenotype. MEFs lacking expression of all three RAS genes do not proliferate but can be rescued by expression of constitutive activation of RAF, but not RAL [28] . This suggests that RAF activation is the key signaling event downstream of RAS for proliferation of MEFs. Because our results show that RAL is also required for proliferation of MEFs, they argue that RAL activation is not downstream of RAS signaling in cell proliferation.
A number of studies suggest that RALA and RALB have distinct roles in cancer cells, RALA being required for tumor cell proliferation and RALB for tumor cell survival and migration [1] . These studies used RNAi in human cancer cell culture models of pancreatic [9] , bladder, and prostate origin [10, 12] . More recently, a requirement for RALA in cell proliferation and survival was shown in human NSCLC cells [29] . Hence, we were surprised to discover that the deletion of either Rala or Ralb does not impair the formation of KRAS G12D -driven tumors in a mouse model of NSCLC. Similarly, we observed that tumor formation was not compromised in the absence of either RALA or RALB in DMBA-TPA-induced skin carcinogenesis or a mouse model of KRAS G12D -driven pancreatic adenocarcinoma (J. Morton, O. Sansom, P.P., and C.J.M., unpublished data). The discrepancy between these results and the RNAibased experiments may be due to the fact that in RNAi studies, RAL is depleted in fully transformed cells, whereas in our genetic system, the Ral gene is deleted at tumor initiation, possibly allowing time for adaptation and compensation during the process of cell transformation. However, if such adaptation is the explanation for the difference between our genetic experiments and RNAi studies, it reinforces the argument that RALA and RALB have redundant functions in tumorigenesis. It will be necessary to induce the genetic deletion of Rals in established tumors to gain further insight into their role in tumor maintenance and to study the requirement for RAL GTPases in the formation of tumors that are not driven by oncogenic RAS.
Overall, this work reveals new roles for RAL GTPases during embryonic development and cell proliferation. Our data strongly support the conclusion that much of RAL signaling can be performed by either RALA or RALB.
Experimental Procedures
Plasmids and Reagents Adenoviruses were obtained from the Gene Transfer Vector Core at the University of Iowa. We used the following primary antibodies: Rala (BD Biosciences, 610222), Ralb (LifeSpan BioSciences, LS-C38719; SCBT, SC-1531; Millipore, 04-037), and GAPDH (Novus Biologicals, NB300-221). Human RALA (GC-Z1257) and RALB (GC-B0022) cDNAs were obtained from GeneCopoeia and transferred using Gateway Technology into pLVXpuro lentiviral vectors (Clontech) containing either enhanced GFP or mCherry (kind gift of Jasmine Abella) and the RfC.1 Gateway cassette (Invitrogen). Lentiviruses were produced in 293T cells cotransfected with pMD2.G and psPAX2 packaging vectors (http://tronolab.epfl.ch/ lentivectors).
Mice
The targeting vectors to generate the Rala and Ralb gene-targeted mice were made by inserting the arms of homology into the pGKNeoF2L2FDTA vector (Phillipe Soriano, Addgene plasmid 13445 [30] ). The homologous recombination was performed in Bruce4 ES cells of C57BL/6J origin (Ozgene). The positive clones were identified by PCR and confirmed by Southern blotting before being injected into albino C57BL/6J blastocysts to generate chimeras in a pure C57BL/6J background. The Rala-and Ralb-targeted mice were crossed to the PGK-Neo or PGK-Flp transgenic (E) Quantification of tumor burden by measuring the area of tumors and total area of lungs on serial cross-sections of the right lobes; mean 6 SD.
(F) Quantification of tumor burden by microCT as described in Figure 2G ; mean 6 SD, representative of three independent experiments (n R 7 for each genotype in each experiment).
(G) Tumors in Kras
G12D
;Rala lox/lox ;Ralb 2/2 mice were scored for RALA protein expression; 40 tumors from 8 animals.
See also Figure S3 .
mice (provided by the Cancer Research UK transgenic facility) to generate the knockout and conditional knockout mice, respectively. The DD1113 Rala gene-trap ES clone was obtained from the Sanger Institute, and the mice were derived at the Cancer Research UK transgenic facility. Images of embryos were captured using a M2FLIII microscope and DC500 camera (Leica Microsystems). The LSL-Kras G12D mice were a generous gift of Dave
Tuveson [31] . The lung tumor experiments were performed on mice with a pure C57BL/6J genetic background. Briefly, the mice were anesthetized with ketamine and xylazine and treated once by intranasal instillation using either 0.5 or 1 3 10 8 pfu/mouse of adenoCre viruses as described in [19] . For the DMBA-TPA-induced skin carcinogenesis experiment, the K14-Cre mice (FVB-Tg(K14-Cre)8Brn) [32] were acquired from the National Cancer Institute Mouse Models of Human Cancers Consortium, and the Ral mice were backcrossed in a FVB/N genetic background for at least six generations. The animals were shaved and treated topically with a single dose of 7,12-dimethylbenzanthracene (DMBA, Sigma-Aldrich) followed by 12-Otetradecanoylphorbol-13-acetate (TPA, Sigma-Aldrich) twice weekly for 20 weeks as described in [33] . The FABP4-Cre (AP2-Cre) mice [16] used to delete floxed Ral alleles in adipocytes were obtained from the Institute of Metabolic Science at the University of Cambridge. Animals were handled in strict accordance with UK Home Office regulations and institutional ethics approval.
Histopathology and Immunohistochemistry
Lungs were perfused and fixed in 10% buffered formalin for 24 hr. The right lobes were embedded in paraffin, and the left lobe was processed for microCT imaging. For IHC against RALA, paraffin sections were pretreated for 2 min in a pressure cooker in citrate buffer (pH 6), washed, blocked 1 hr in mouse IgG block (VECTASTAIN) and then 5 min in protein block (Dako X0909), incubated 1 hr with anti-RALA antibody (1:250; BD Biosciences, 610222), washed, incubated 30 min in Mouse EnVision (Dako), washed, incubated 5 min in diaminobenzene, washed, and counterstained with Gill's hematoxylin. The washes were all performed using Dako FLEX Wash Buffer (K8000). The RALA antibody was validated for IHC with WT and Rala null MEFs that were formalin fixed and paraffin embedded ( Figure S1I ).
MicroCT Analysis
After being fixed in formalin, lungs were dehydrated in ethanol (35%, 2 hr; 70%, 2 hr; 80%, 2 hr; 90%, 2 hr; 100%, 12 hr), transferred to hexamethyldisilazane (Sigma-Aldrich, #52619) for 2 hr, and dried for 12 hr. The lungs were scanned in a SkyScan 1076 microCT scanner (Bruker microCT) with the following settings: Styrofoam bed, no filter, 18 mm resolution, 40 kV, 120 ms exposure, and 0.4 rotation step. The scans were reconstructed and analyzed using NRecon and CTAn software, respectively (Bruker microCT).
Cell Culture and Pull-Down Assays MEFs were isolated from E13.5 embryos and cultured in a low-oxygen (3%) incubator [34] in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. For analysis of RAL-GTP levels, 1 3 10 6 cells were lysed in 650 ml of ice-cold Ral lysis buffer (50 mM Tris [pH 7.4], 10% glycerol, 1% NP40, 5 mM MgCl 2 , 100 mM NaCl, 1 mM dithiothreitol [DTT] , and cOmplete EDTA-free Protease Inhibitor; Roche). The lysates were spun at 13,000 rpm at 4 C for 15 min. Next, 400 ml of the supernatant was incubated with 25 ml of glutathione Sepharose beads bound to approximately 50 mg glutathione S-transferase-RalBP1 RBD proteins at 4 C for 45 min. The beads were spun at 4 C for 5 min at 1,000 3 g and washed twice with 1 ml of Ral wash buffer (Tris-buffered saline, 10 mM MgCl 2 , 1 mM DTT, and cOmplete EDTAfree Protease Inhibitor) before being resuspended in Laemmli loading buffer containing 100 mM DTT. Immunoblotting analyses were performed using an Odyssey Imaging System (LI-COR Biosciences) according to the manufacturer's instructions. Confocal images were acquired with a Zeiss LSM 7 microscope, and images were processed and analyzed with Volocity (PerkinElmer).
Supplemental Information
Supplemental Information includes four figures and can be found with this article online at http://dx.doi.org/10.1016/j.cub.2012.09.013. (E) Quantification of western blots of three independent experiments; mean 6 SD (**p % 0.01).
(F) Levels of RALA-GTP and total RALA in two independent populations of WT and Ralb 2/2 MEFs.
(G) Quantification of data from (F), as in (E); mean 6 SD. See also Figure S4 .
